Peresolimab (anti-PD-1) ExactAb™, Low Endotoxin, Azide Free, Carrier Free, Validated, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182993-100ΜG / 100ΜG
CAS No.:2411580-63-5
Peresolimab (anti-PD-1) ExactAb™, Low Endotoxin, Azide Free, Carrier Free, Validated, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182993-10MG / 10MG
CAS No.:2411580-63-5
Peresolimab (anti-PD-1) ExactAb™, Low Endotoxin, Azide Free, Carrier Free, Validated, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182993-1MG / 1MG
CAS No.:2411580-63-5
Peresolimab (anti-PD-1) ExactAb™, Low Endotoxin, Azide Free, Carrier Free, Validated, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182993-5MG / 5MG
CAS No.:2411580-63-5
Linvoseltamab (anti-BCMA&CD3) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB182996-100ΜG / 100ΜG
CAS No.:2408319-25-3
Linvoseltamab (anti-BCMA&CD3) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB182996-10MG / 10MG
CAS No.:2408319-25-3
Linvoseltamab (anti-BCMA&CD3) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB182996-1MG / 1MG
CAS No.:2408319-25-3
Linvoseltamab (anti-BCMA&CD3) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB182996-5MG / 5MG
CAS No.:2408319-25-3
Osemitamab (anti-CLDN18.2) Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183000-100ΜG / 100ΜG
CAS No.:2460539-61-9
Osemitamab (anti-CLDN18.2) Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183000-10MG / 10MG
CAS No.:2460539-61-9
Osemitamab (anti-CLDN18.2) Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183000-1MG / 1MG
CAS No.:2460539-61-9
Osemitamab (anti-CLDN18.2) Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183000-5MG / 5MG
CAS No.:2460539-61-9
Mipasetamab (anti-AXL) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183002-100ΜG / 100ΜG
CAS No.:2361055-48-1
Mipasetamab (anti-AXL) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183002-10MG / 10MG
CAS No.:2361055-48-1
Mipasetamab (anti-AXL) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183002-1MG / 1MG
CAS No.:2361055-48-1
Mipasetamab (anti-AXL) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183002-5MG / 5MG
CAS No.:2361055-48-1
Pivekimab (anti-CD123) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183003-100ΜG / 100ΜG
CAS No.:2234335-84-1
Pivekimab (anti-CD123) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183003-10MG / 10MG
CAS No.:2234335-84-1
Pivekimab (anti-CD123) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183003-1MG / 1MG
CAS No.:2234335-84-1
Pivekimab (anti-CD123) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, 重組, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183003-5MG / 5MG
CAS No.:2234335-84-1
Abciximab (anti-Integrin αIIbβ3) Low Endotoxin, Azide Free, Validated, Recombinant, Carrier Free, ExactAb™, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183009-100ΜG / 100ΜG
CAS No.:143653-53-6
Abciximab (anti-Integrin αIIbβ3) Low Endotoxin, Azide Free, Validated, Recombinant, Carrier Free, ExactAb™, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183009-10MG / 10MG
CAS No.:143653-53-6
Abciximab (anti-Integrin αIIbβ3) Low Endotoxin, Azide Free, Validated, Recombinant, Carrier Free, ExactAb™, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183009-1MG / 1MG
CAS No.:143653-53-6
Abciximab (anti-Integrin αIIbβ3) Low Endotoxin, Azide Free, Validated, Recombinant, Carrier Free, ExactAb™, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183009-5MG / 5MG
CAS No.:143653-53-6
Reslizumab (anti-IL-5) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183026-100ΜG / 100ΜG
CAS No.:241473-69-8
Reslizumab (anti-IL-5) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183026-10MG / 10MG
CAS No.:241473-69-8
Reslizumab (anti-IL-5) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183026-1MG / 1MG
CAS No.:241473-69-8
Reslizumab (anti-IL-5) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183026-5MG / 5MG
CAS No.:241473-69-8
Pritumumab (anti-Vimentin) RUO, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183037-100ΜG / 100ΜG
CAS No.:499212-74-7
Pritumumab (anti-Vimentin) RUO, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183037-10MG / 10MG
CAS No.:499212-74-7
Pritumumab (anti-Vimentin) RUO, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183037-1MG / 1MG
CAS No.:499212-74-7
Pritumumab (anti-Vimentin) RUO, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183037-5MG / 5MG
CAS No.:499212-74-7
Sontuzumab (anti-MUC1) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB183059-100ΜG / 100ΜG
CAS No.:372075-37-1
Sontuzumab (anti-MUC1) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB183059-10MG / 10MG
CAS No.:372075-37-1
Sontuzumab (anti-MUC1) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB183059-1MG / 1MG
CAS No.:372075-37-1
Sontuzumab (anti-MUC1) 無載體, 重組, ExactAb™, 低內毒素, Azide Free, 已驗證, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB183059-5MG / 5MG
CAS No.:372075-37-1
Inolimomab (anti-IL2RA) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183060-100ΜG / 100ΜG
CAS No.:152981-31-2
Inolimomab (anti-IL2RA) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183060-10MG / 10MG
CAS No.:152981-31-2
Inolimomab (anti-IL2RA) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183060-1MG / 1MG
CAS No.:152981-31-2
Inolimomab (anti-IL2RA) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183060-5MG / 5MG
CAS No.:152981-31-2
Iratumumab (anti-CD30) Carrier Free, 重組, Low Endotoxin, Azide Free, Validated, ExactAb™, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183073-100ΜG / 100ΜG
CAS No.:640735-09-7
Iratumumab (anti-CD30) Carrier Free, 重組, Low Endotoxin, Azide Free, Validated, ExactAb™, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183073-10MG / 10MG
CAS No.:640735-09-7
Iratumumab (anti-CD30) Carrier Free, 重組, Low Endotoxin, Azide Free, Validated, ExactAb™, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183073-1MG / 1MG
CAS No.:640735-09-7
Iratumumab (anti-CD30) Carrier Free, 重組, Low Endotoxin, Azide Free, Validated, ExactAb™, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183073-5MG / 5MG
CAS No.:640735-09-7
Sibrotuzumab (anti-FAP) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183093-100ΜG / 100ΜG
CAS No.:216669-97-5
Sibrotuzumab (anti-FAP) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB183093-10MG / 10MG
CAS No.:216669-97-5